Evidence map›Paper›PMID 36701113›Full record

ArticleDrug delivery and translational research2023

Fabrication and characterization of bilayer scaffolds made of decellularized dermis/nanofibrous collagen for healing of full-thickness wounds.

Naser Amini, Ahmad Hivechi, Shiva Asadpour, Kaveh Ebrahimzadeh, Saeid Kargozar, Mazaher Gholipourmalekabadi, Ahvan Nasrolahi, Melina Ghasemian, Amir Shafaat, Masoud Mozafari and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naser AminiCellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Ahmad HivechiCellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Shiva AsadpourDepartment of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Kaveh EbrahimzadehDepartment of Neurosurgery, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Saeid KargozarTissue Engineering Research Group (TERG), Department of Anatomy and Cell Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mazaher GholipourmalekabadiCellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Ahvan NasrolahiCellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran.
Melina GhasemianDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Amir ShafaatDepartment of Mechanical Engineering, Arak University of Technology, Arak, Iran.
Masoud MozafariDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Peiman Brouki Milan *Cellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran, Iran. Peiman.brouki@gmail.com.ORCID http://orcid.org/0000-0002-3602-2960
Alireza Rezapour *Cellular and Molecular Research Centre, Qom University of Medical Sciences, Qom, Iran. Alireza.Rezapour@yahoo.com.ORCID http://orcid.org/0000-0002-2160-4730

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin tissue engineering has progressed from simple wound dressings to biocompatible materials with desired physico-chemical properties that can deliver regenerative biomolecules. This study describes using a novel biomimetic hybrid scaffold of decellularized dermis/collagen fibers that can continuously deliver stromal cell-derived factor-1 alpha (SDF-1α) for skin regeneration. In diabetic rat models, the idea that sustained SDF-1α infusion could increase the recruitment of CXCR4-positive cells at the injury site and improve wound regeneration was investigated. The morphology of the scaffold, its biocompatibility, and the kinetics of SDF-1 release were all assessed. SDF-1α was successfully incorporated into collagen nanofibers, resulting in a 200-h continuous release profile. The microscopic observations exhibited that cells are attached and proliferated on proposed scaffolds. As evaluated by in vivo study and histological examination, fabricated scaffold with SDF-1α release capacity exhibited a remarkably more robust ability to accelerate wound regeneration than the control group. Besides, the SDF-1α-loaded scaffold demonstrated functional effects on the proliferation and recruitment of CD31 and CXCR4-positive cells in the wound bed. Additionally, no adverse effects such as hyperplasia or scarring were found during the treatment period. It may be concluded that the fabricated hybrid scaffold based on natural polymer opens up a new option for topical administration of bioactive molecules. We believe the SDF-1α-loaded hybrid scaffold has promise for skin tissue engineering.

Indexed as

Chemokine CXCL12NanofibersAnimalsCollagenDermisRatsTissue ScaffoldsChemokine CXCL12CollagenDecellularized dermal matrixElectrospinningHybrid scaffoldsSDF-1αWound healing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.